Preview

Современная ревматология

Расширенный поиск

Кардиоренальный синдром у больных ревматоидным артритом

https://doi.org/10.14412/1996-7012-2019-3-82-86

Полный текст:

Аннотация

Термин «кардиоренальный синдром» (КРС) предложен в 2008 г. инициативной группой Acute Dialysis Quality Initiative (ADQI) для обозначения патологических взаимообусловленных состояний с вовлечением сердца и почек, развивающихся вследствие острой или хронической дисфункции одного из органов с последующей острой или хронической дисфункцией другого. Проблема КРС у больных ревматоидным артритом (РА) не изучалась. Наибольший интерес представляет КРС 5-го типа, или «вторичный» КРС, возникающий у пациентов с системными заболеваниями, в том числе с РА. В настоящее время не вызывает сомнений то, что у больных РА риск развития кардиоваскулярных заболеваний, распространенность неишемической и ишемической хронической сердечной недостаточности (ХСН) выше, чем в общей популяции. Имеются данные о высокой распространенности хронической болезни почек (ХБП) и ассоциированных с почечной патологией кардиоваскулярных факторов риска (ФР) у пациентов с РА. Помимо традиционных ФР развития сердечно-сосудистых заболеваний и заболеваний почек, аутоиммунное воспаление является независимым предиктором ХСН и ХБП. Изучение особенностей КРС при РА необходимо для выработки эффективной стратегии лечения этой категории пациентов.

Об авторах

З. Ю. Мутовина
Центральная государственная медицинская академия Управления делами Президента Российской Федерации
Россия

Мутовина Зинаида Юрьевна.

121359, ул. Маршала Тимошенко, 19, стр. 1А.



А. И. Загребнева
Городская клиническая больница №52 Департамента здравоохранения города Москвы
Россия

123182, Москва, ул. Пехотная, 3.



Е. А. Галушко
Научно-исследовательский институт ревматологии им. В.А. Насоновой
Россия

115522, Москва, Каширское шоссе, 34А.



А. В. Гордеев
Научно-исследовательский институт ревматологии им. В.А. Насоновой
Россия

115522, Москва, Каширское шоссе, 34А.



Литература

1. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. JAm Coll Cardiol. 2008 Nov 4;52(19):1527-39. doi: 10.1016/j.jacc.2008.07.051.

2. Ronco C. Cardiorenal and renocardial syndromes: clinical disorders in search of a systematic definition. Int JArtif Organs. 2008 Jan;31(1):1-2.

3. Jose P, Skali H, Anavekar N, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006 Oct;17(10):2886-91. Epub 2006 Aug 23.

4. Cowie MR, Komajda M, Murray-Thomas T, et al. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006 May;27(10): 1216-22. Epub 2006 Apr 19.

5. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol. 2006 Jan; 1(1):8-18. Epub 2005 Dec 22.

6. Ronco C, McCullough SD. Cardiorenal syndromes: reports from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010 Mar;31(6):703-11. doi: 10.1093/eurheartj/ehp507. Epub 2009 Dec 25.

7. Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007 Aug;13(6):422-30.

8. Bagshaw SM. The long-term outcome after acute renal failure. Curr Opin Crit Care. 2006 Dec;12(6):561-6.

9. Khosla N, Soroko SB, Chertow GM, et al. Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury Clin J Am Soc Nephrol. 2009 Dec;4(12): 1914-9. doi: 10.2215/CJN.01690309. Epub 2009 Nov 25.

10. Coresh IJ, Stevens L, Levery A. Chronic kidney disease is common: What do we do next? Nephrol Dial Transplant. 2008 Apr;23(4): 1122-5. doi: 10.1093/ndt/gfn117.

11. McClellan W. The epidemic of renal disease — what drives it and what can be done? Nephrol Dial Transplant. 2006 Jun;21(6): 1461-4.

12. Bagshaw SM, Lapinsky S, Dial S, et al. Acute kidney injure in septic shock: clinical outcome and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 2009 May;35(5): 871-81. doi: 10.1007/s00134-008-1367-2. Epub 2008 Dec 9.

13. Kotecha A, Vallabhajosyula S, Coville HH, et al. Cardiorenal syndrome in sepsis: A narrative review. J Crit Care. 2018 Feb;43:122-127. doi: 10.1016/j.jcrc.2017.08.044. Epub 2017 Sep 1.

14. Krag A, Bendtsen F, Burroughs AK, M0ller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012 Jul;79(1): 53-5. doi: 10.1016/j.mehy.2012.03.032. Epub 2012 Apr 24.

15. Gigante A, Barilaro G, Barbano B, et al. Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis. Cardiorenal Med. 2016 Feb;6(2):135-42. doi: 10.1159/000442996. Epub 2016 Jan 23.

16. Ребров АП, Оксеньчук АН, Карпова ОГ. Встречаемость хронической болезни почек и ее структура у больных с системной красной волчанкой. Современные проблемы науки и образования. 2013;(3):130.

17. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999 Nov;26(11):2475-9.

18. Del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001 Dec;44(12):2737-45.

19. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003 Mar 11;107(9):1303-7.

20. Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. JRheumatol. 2003 Jan;30(1):36-40.

21. Watson D, Rhodes T, Guess H. All-cause mortality and vascular events among patients with RA, OA, or no arthritis in the UK General Practice Research Database. J Rheumatol. 2003 Jun;30(6):1196-202.

22. Fischer LM, Schlienger RG, Matter C, et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 2004 Jan 15;93(2):198-200.

23. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005 Feb; 52(2):402-11.

24. Nicola PJ, Maradit-Kremers H, Roger VL, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005 Feb;52(2):412-20.

25. Mantel A, Holmqvist M, Andersson DC, et al. Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure. J Am Coll Cardiol. 2017 Mar 14;69(10):1275-1285. doi: 10.1016/j.jacc.2016.12.033.

26. Myasoedova E, Crowson CS, Nicola PJ, et al. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011 Aug;38(8):1601-6. doi: 10.3899/jrheum.100979. Epub 2011 May 15.

27. Udayakumar N, Venkatesan S, Rajendiran C. Diastolic function abnormalities in rheumatoid arthritis: relation with duration of dis¬ease. Singapore Med J. 2007 Jun;48(6):537-42.

28. Szekanesz Z, Kerekes G, Kordos G, et al. Mechanisms of inflammatory atherosclerosis in rheumatoid arthritis. Curr Immunol Rev. 2016;12(1):35-46. doi: 10.2174/1573395511666150706181454.

29. Hollan I, Meroni PL, Ahearn JM, et al. Cardiovascular disease in autoimmune rheu-matic diseases. Autoimmun Rev. 2013 Aug; 12(10):1004-15. doi: 10.1016/j.autrev.2013.03.013. Epub 2013 Mar 27.

30. Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv4-7. doi: 10.1093/rheumatology/kel313/

31. Szekanesz Z, Kerekes G, Sandor Z, et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann N YAcad Sci. 2007 Jun;1108: 349-58.

32. Szekanecz Z, Kerekes G, Vegh E, et al. Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do. Autoimmun Rev. 2016 Jul;15(7):756-69. doi: 10.1016/j.autrev.2016.03.014.

33. Nakano M, Ueno M, Nishi S, et al. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol. 1998 Sep;50(3):154-60.

34. Helin HJ, Korpela MM, Mustonen JT, et al. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum. 1995 Feb;38(2):242-7.

35. Karie S, Gandjbakhch F, Janus N, et al. Kidney disease in RA patients: prevalence and implication on RA-related drugs man-agement: the MATRIX study. Rheumatology (Oxford). 2008 Mar;47(3):350-4. doi: 10.1093/rheumatology/kem370. Epub 2008 Jan 31.

36. Hickson LJ, Crowson CS, Gabriel SE, et al. Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis. 2014 Feb;63(2):206-13. doi: 10.1053/j.ajkd.2013.08.010. Epub 2013 Oct 4.

37. Shankar A, Sun L, Klein BE, et al. Markers of inflammation predict the long-term risk of developing chronic kidney dis-ease: a population-based cohort study. Kidney Int. 2011 Dec;80(11):1231-8. doi: 10.1038/ki.2011.283. Epub 2011 Aug 24.

38. Hiramoto JS, Katz R, Peralta CA, et al. Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2012 Aug;60(2):225-32. doi: 10.1053/j.ajkd.2012.02.335. Epub 2012 May 4.

39. Kochi M, Kohagura K, Shiohira Y, et al. Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis. PLoSOne. 2016 Aug 18;11(8): e0160225. doi: 10.1371/journal.pone.0160225. eCollection 2016.

40. Sumida K, Molnar MZ, Potukuchi PK, et al. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. Kidney Int. 2018 May;93(5):1207-1216. doi: 10.1016/j.kint.2017.11.025. Epub 2018 Mar 2.

41. Kochi M, Kogahura K, Shiohira Y, et al. Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis. J Cardiol. 2018 Mar;71(3):277-283. doi: 10.1016/j.jjcc.2017.08.008. Epub 2017 Sep 30.

42. Van Sijl AM, van den Oever IA, Peters MJ, et al. Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRE Study. Ann Rheum Dis. 2012 Mar;71(3):341-4. doi: 10.1136/annrheumdis-2011-200051. Epub 2011 Sep 27.

43. Chiu HY, Huang HL, Li CH, et al. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications — A National Population-Based Cohort Study. PLoS One. 2015 Sep 25;10(9):e0136508. doi: 10.1371/journal.pone.0136508. eCollection 2015.

44. Meune C, Touze E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a sys¬tematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2009 Oct; 48(10):1309-13. doi: 10.1093/rheumatology/kep252. Epub 2009 Aug 20.

45. Solomon DH, Kremer J, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk fac-tors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010 Nov;69(11): 1920-5. doi: 10.1136/ard.2009.122226. Epub 2010 May 5.

46. Karie S, Gandjbakhch F, Janus N, et al. Kidney disease in RA patients: prevalence and implication on RA-related drugs man-agement: the MATRIX study. Rheumatology (Oxford). 2008 Mar;47(3):350-4. doi: 10.1093/rheumatology/kem370. Epub 2008 Jan 31.

47. Karstila K, Korpela M, Sihvonen S, Mustonen J. Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol. 2007 Dec;26(12):2089-2095. doi: 10.1007/s10067-007-0625-y. Epub 2007 May 10.

48. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.

49. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney dis-ease in a large managed care organization. Arch Intern Med. 2004 Mar 22;164(6):659-63.

50. Bongartz LG, Cramer MJ, Doevendans PA, et al. The severe cardiorenal syndrome: «Guyton revisited». Eur Heart J. 2005 Jan; 26(1):11-7. Epub 2004 Nov 30.

51. Fabbian F, Pala M, De Giorgi A, et al. Features of Cardio-Renal Syndrome in a Cohort of Consecutive Patients Admitted to an Internal Medicine Ward. Open Cardiovasc Med J. 2011;5:220-5. doi: 10.2174/1874192401105010220. Epub 2011 Nov 18.

52. Haroon M, Adeeb F, Devlin J, et al. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis. Int J Rheum Dis. 2011 Aug;14(3):255-60. doi: 10.1111/j.1756-185X.2011.01594.x. Epub 2011 Apr 4.


Для цитирования:


Мутовина З.Ю., Загребнева А.И., Галушко Е.А., Гордеев А.В. Кардиоренальный синдром у больных ревматоидным артритом. Современная ревматология. 2019;13(3):82-86. https://doi.org/10.14412/1996-7012-2019-3-82-86

For citation:


Mutovina Z.Y., Zagrebneva A.I., Galushko E.A., Gordeev A.V. Cardiorenal syndrome in patients with rheumatoid arthritis. Modern Rheumatology Journal. 2019;13(3):82-86. (In Russ.) https://doi.org/10.14412/1996-7012-2019-3-82-86

Просмотров: 43


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)